Emory and Georgia Memory Net tell committee new Alzheimer's diagnostics and infusions require expanded clinic capacity and state support Emory researchers and Georgia Memory Net told the committee that FDA-authorized blood diagnostics (p-tau217) and new antibody infusion treatments can slow Alzheimer's progression but require more memory assessment clinics, infusion capacity and monitoring; presenters said the state program reaches about 6,000 people and receives roughly $7.12 million in state support.

Groundbreaking antibody infusions and FDA-authorized blood diagnostics could reshape Alzheimer's treatment, but the program needs your support to expand access across Georgia!

Learn more here

#GA #PublicHealthInnovation #HealthcareAccess #CitizenPortal #GeorgiaMemoryHealth #Research